等待开盘 06-26 09:30:00 美东时间
+0.830
+9.06%
Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major catalyst in the PV market.
06-25 02:22
Silence Therapeutics says SANRECO data show sustained polycythemia vera benefits as analysts weigh divesiran's profile against rusfertide.
06-12 22:47
HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 price target.
2025-03-07 19:59
07:46 AM EDT, 09/03/2024 (MT Newswires) -- Silence Therapeutics (SLN) has average rating of buy and price targets ranging from $40 to $75, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, As...
2024-09-03 19:46
11:10 AM EDT, 08/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Friday morning, nudging down 0.03% to 1,476.31 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and ...
2024-08-30 23:10
HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 price target.
2024-08-30 17:44
11:25 AM EDT, 08/26/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts edged lower late Monday morning, declining 0.12% to 1,470.85 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and semi...
2024-08-26 23:25
Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $55 price target.
2024-08-16 18:30